Hyperfibrotic myelodysplastic syndrome: a report of three cases from north India

Prasenjit Das1, Deepali Jain, Reena Das

  • 1R,8/2, Ramesh Park, Laxmi Nagar 110092 Delhi - India,

Insights

Extensive fibrosis is rare in myelodysplastic syndromes (MDS). This report details three unique cases of hyperfibrotic MDS, suggesting it warrants separate classification due to its distinct presentation and poor prognosis.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Extensive bone marrow fibrosis is an uncommon finding in MDS.
  • Hyperfibrotic MDS presents a distinct subtype with unique pathological features.

Purpose of the Study:

  • To report and characterize rare cases of hyperfibrotic myelodysplastic syndromes.
  • To discuss the implications of hyperfibrotic MDS classification.
  • To highlight the clinical significance and prognostic implications of this rare MDS subtype.

Main Methods:

  • Case series reporting.
  • Review of clinical data and bone marrow pathology.
  • Differential diagnosis considerations within myeloid neoplasms.

Main Results:

  • Three cases of hyperfibrotic MDS were identified.
  • These cases exhibited distinct clinical and pathological characteristics.
  • Variable clinical presentations were observed across the reported cases.

Conclusions:

  • Hyperfibrotic MDS is a rare entity that requires recognition.
  • This subtype may necessitate separate classification within myeloid neoplasms.
  • Hyperfibrotic MDS is associated with a poor prognosis, underscoring the need for further research and tailored management strategies.

Related Concept Videos